Immunsuppression, abstoßungsdiagnostik und -therapie nach pankreastransplantation

Chirurgische Gastroenterologie mit Interdisziplinaren Gesprachen

Volumn 12, Issue SUPPL. 1, 1996, Pages 38-43

  Busing M ^a   Martin, D ^a   Riege, R ^a   Hopt, U T ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Chir Univ Klin Rostock

Author keywords

Immunosuppression; Pancreas transplantation; Rejection; Rejection therapy

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CYCLOSPORIN; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

DRUG EFFICACY; GRAFT REJECTION; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PANCREAS TRANSPLANTATION; REVIEW;

EID: 0030002052     PISSN: 01779990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Sutherland DER: IPTR (International Pancreas Transplant Registry Report). Transplant Proc 1995 (in press).
2. Hopt UT, Büsing M, Schareck WD, Becker HD: Management der exokrinen Pankreassekretion - ein zentrales Problem der allogenen Pankreastransplantation. Chirurg 1992;63:186-192.
3. Busing M, Martin D, Riege R, et al: Die kombinierte Pankreas-/Nierentransplantation als Standardverfahren in der Therapie niereninsuffizienter Typ-I-Diabetiker. Chirurg 1996 (im Druck).
4. Busing M, Schareck WD, Irkin I, Hopt UT: Diagnose und Management der Abstoßungsreaktion nach kombinierter Pankreasduodenal-/Nierentransplantation. Transplantationsmed 1991;3:66-71.
5. Brattström C, Tyden G, Reinhold FP, et al: Marker for pancreas-graft rejection in humans. Diabetes 1989;38:57-62.
6. Ames SA, Corry RJ: Diagnosis of pancreas transplant rejection: Use of noninvasive tests to asses initial disfunction in combined pancreas-kidney transplants. Transplant Proc 1989;21:3639-3642.
7. Nankivell BJ, Allen RMD, Bell B, et al: Urinary amylase measurement for detection of bladder-drained pancreatic allograft rejection. Transplant Proc 1990;22:2157-2158.
8. Pfeffer F, Nauck M, Makowiec F, et al: Der Effekt von CCK auf die exokrine Pankreassekretion beim Menschen ist abhängig von einer intakten extrinsischen Innervation; in Trade, Seifert, Hartel (Hrsg): Chirurgisches Forum 1994 für experimentelle und klinische Forschung. Berlin, Springer, 1994, pp283-288.
9. Elkharnmas EA, Henry ML, Tesi RJ, Ferguson RM: Combined kidney/pancreas transplantation at the Ohio state university hospitals; in Terasaki PJ, Cecka JM (eds): Clinical Transplants. Los Angeles, UCLA Tissue Typing Laboratory. 1993, pp191-197.
10. Margreiter R, Klima G, Bösmüller C, Königsrainer A, Schmid T, Steiner E: Rejection of kidney and pancreas after pancreas/kidney Transplantation. Diabetes 1989;38:79-81.
11. Stratta RJ, Taylor RJ, Bynon JS, et al: Surgical treatment of diabetes mellitus with pancreas transplantation. Ann Surg 1994;120:809-817.
12. Perkins JD, Engen DE, Munn SR, et al: The value of cytoscopically-directed biopsy in human pancreaticoduodenal transplantation. Clin Transplant 1989;3:306-315.
13. Egidi MF, Randhawa P, Pietrzak B, Corry RJ: Fine needle aspiration biopsy (FNAB) in pancreatic transplantation. Transplant Proc 1996 (in press).
14. Stratta R, Taylor R, Grune M, et al: Experience with protocol biopsies after solitary pancreas transplantation (SPTx). Transplant Int 1996 (in press).
15. Eckhoff DE, Sollinger HW: Surgical complications after simultaneous pancreas-kidney transplants with bladder drainage; in Terasaki PJ, Cecka JM (eds): Clinical Transplants. Los Angeles, UCLA Tissue Typing Laboratory, 1994,pp185-191.
16. Hopt UT, Benz S, Pfeffer F, et al: Simultaneous pancreas/kidney transplantation - the optimal therapy for type I diabetics with end-stage renal disease in Europe, too? Transplant Int 1994; 7:414-416.
17. Stratta R, Taylor R, Sindhi R, et al: Is there a transfusion (TX) effect in combined pancreas-kidney transplantation (PKT)? Transplant Proc 1996 (in press).
18. Hopt UT, Busing M, Schareck WD, et al: Is HLA-matching worthwhile in pancreatic transplantation? Transplant Proc 1992;24:909-910.
19. Wadström J, Brekke B, Wrammer H, et al: Triple versus quadruple immunosuppression in pancreas transplantation. Transplant Proc 1995;27:1317-1318.
20. Sutherland DER, Moudry-Munns K, Gruessner A: Pancreas transplants results in United Network for Organ Sharing (UNOS) United States of America (USA) registry with comparison to non-USA data in the international registry; in Terasaki PJ, Cecka JM (eds): Clinical Transplants. Los Angeles, UCLA Tissue Typing Laboratory, 1994,pp47-70.
21. Stratta R, Taylor R, Weide L, et al: A prospective trial of OKT3 versus ATGAM induction therapy in pancreas transplant (PTX) recipients. Transplant Int 1996 (in press).
22. Busing M, Mellert J, Greger B, Hopt UT: Acute respiratory insufficiency due to OKT3 therapy. Transplant Proc 1990;22:1779-1781.
23. Beilman GJ, Shield CF, Hughes JD, et al: The effects of intraoperative administration of OKT3 during renal transplantation. Transplantation 1993, 55:490-493.
24. Sutherland DER: A commentary to: Immunosuppression for pancreas transplant recipients (Land W.); in Dubernard JM, Sutherland DER (eds): Pancreastransplantation. Dordrecht, Kluwer, 1989, pp184-186.
25. Büsing M, Mellert J, Greger B, Hopt UT: Stellt eine gute HLA-Übereinstimmung eine Voraussetzung für eine gute Transplantatfunktion nach isolierter Nieren-/bzw. Pankreas-Nierentransplantation dar? Nieren-/Hochdruckkrankh 1990; 19: 296-300.
26. Büsing M, Hopt UT, Quacken M, et al: Morphological studies of graft pancreatitis following pancreas transplantation. Br J Surg 1993;80:1170-1173.
27. Kuroda T, Shiohara E, Homma T, et al: Effects of leukocyte and platelet depletion on ischemia-reperfusion injury to dog pancreas. Gastroenterology 1994;107:1125-1134.
28. Sollinger HW, Geffner SR: Pancreas transplantation. Surg Clin North Am 1994;74:1183-1195.
29. Teraoka S, Babazono T, Koike T, et al: Effect of rescue therapy using FK 506 on relapsing rejection after combined pancreas and kidney transplantation. Transplant Proc 1995;27:1335-1339.
30. Hopt UT, Pfeffer F, Schareck W, et al: Ganciclovir for prophylaxis of CMV disease after pancreas/kidney transplantation. Transplant Proc 1994;26:434-435.
31. Kohli V, Velosa J, Sterioff S, Munn S: Prophylaxis for cytomegalovirus (CMV) infection in pancreas transplant recipients using ganciclovir. Transplant Proc 1996 (in press).
32. Conti DJ, Freed BM, Singh TP, et al: Preemptive ganciclovir therapy in cytomegalovirus-seropositive renal transplant recipients. Arch Surg 1995; 130:1217-1222.
33. Halloran PF, Batiuk TD, Goes NB, Campbell P: Strategies to improve the immunologic management of organ transplants. Clin Transplant 1995; 9:227-236.
34. Yoshimura N, Matsui S, Hamashima T, Oka I: Effect of a new immunosuppressive agent, FK 506, on human lymphocyte responses in vitro. II. Inhibition of the production of IL-2 and gamma-IFN, but not B cell-stimulating factor 2. Transplantation 1989;47:356.
35. Winkler M, Christians U: A risk-benefit assessment of tacrolimus in transplantation. Drug Safety 1995;12:348-357.
36. Jordan ML, Shapiro K, Vivas CA, et al: 506 salvage of renal allografts with ongoing rejection failing cyclosporin immunosuppression. Transplant Proc 1993;25:638-640.
37. Shapiro R, Jordan M, Scantlebury V, et al: Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: A preliminary report. Transplant Proc 1993; 25:669-672.
38. Gruessner RWG, Drangstveit MB, Gruessner A, et al: FK 506 for induction and rescue therapy after pancreas (PA) transplantation (TX). Transplant Proc 1996 (in press).
39. Stratta R, Taylor R, Castaldo P, et al: Preliminary experience with FK 506 (FK) in pancreas transplant (PTX) recipients. Transplant Int 1996 (in press).
40. Ketel BL, Reed KN, Barone BSN, Barone GW: Initial results of tacrolimus maintenance therapy in combined kidney and pancreas transplantation. Transplant Int 1996 (in press).
41. Sollinger HW, Deierhoi MH, Belzer FO, et al: RS-61443 - a phase I clinical trial and pilot rescue study. Transplantation 1992;33:428-432.
42. European Mycophenolate Mofetil Cooperative Study Group: Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995;345:1321-1325.
43. Todo S, Reyes J, Furukawa H, et al: Outcome analysis of 71 clinical intestinal transplantations. Ann Surg 1995;222:270-282.
44. Burke GW, Ricordi C, Karatzas T, et al: Donor bone marrow infusion in simultaneous pancreas/kidney (SPK) transplant recipients: A preliminary study. Transplant Proc 1996 (in press).